September 17-18, 2018
Lisbon, Portugal
ABOUT CONFERENCE:
Vaccine Design 2018 welcomes attendees, presenters, and exhibitors from all over the world to Lisbon, Portugal. We are delighted to invite you all to attend and register for the “24th International Conference on Vaccine Design, Production & Safety” which is going to be held during September 17-18, 2018 Lisbon, Portugal.
Vaccine Design 2018 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation.
At PULSUS Group, it is our ideology to bring maximum exposure to our attendees, so we make sure the event is a blend which covers professionals such as medical researchers, scientists,Physicians, industry professionals, Immunologist from academia & industry making the Vaccine Design 2018 conference a perfect platform.
The conference will be organized around the Theme ‘Exploring, Envisioning Innovations on Vaccine Designing’. Our goal is to deliver an outstanding program which covers the entire spectrum of research & innovations in vaccine designing and share the cross-cultural experiences of various production and safety procedures.
Vaccine Design 2018 aims in gathering the eminent research communities catalyzing information exchange and networking between researchers and business entrepreneurs of diverse backgrounds fostering advancements in Vaccine Design research.
2018 Highlights:
Why to attend???
With members from around the world focused on learning about vaccine administration, safety and its advances; this is your best opportunity to reach the largest assemblage of participants from the Immunologists, Healthcare professionals and Industries. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new discoveries in vaccine designing , and receive name recognition at this 2-day event. World renowned Speakers, the most recent techniques, developments, and the newest updates in Methods of designing vaccines, Vaccine production technologies, Storage and maintenance of vaccines are hallmarks of this conference.
Target Audience:
Conference Opportunities
For Researchers and Faculty Members:
For Universities, Associations & Societies:
For Students and Research Scholars:
For Business Delegates:
For Product Manufacturers:
Pulsus Group invites all the participants from all over the world to attend “24th International Conference on Vaccine Design, Production & Safety” to be held on September 17-18, 2018, Lisbon, Portugal which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
Session 01: Production and Research of Vaccines
Production and Research of Vaccines with the emergence and growth of new diseases, the need and demand for innovative vaccines continues to grow. But vaccine development is a complex, laborious, and expensive process.There are challenges faced during discovery of vaccines. It involves a demand of multiple technologies, sufficient funds for clinical trials and manufacturing facilities, sophisticated scale-up processes, knowledge in navigating demanding regulatory environments in various regions, and managing vital safety monitoring.
Related Conferences:
Conference on Strategic Partnering for the Global Vaccine Industry, October 29-31, 2018, Lisbon, Portugal; Global Summit on Vaccines and Vaccination, August 23-25, 2018, Las Vegas, USA; World Vaccine Congress Washington congress, April 14- 17, 2019, Washington DC, USA; International Conference on Vaccines Research & Development, November 13-15, 2018, Baltimore, MD; 3rd International Conference on Immunology and Vaccines, November 7-9, 2018, Tokyo, Japan; Annual Congress on Vaccines and Clinical Trials, July 27-28, 2018, Vancouver, Canada; 33rd Annual Vaccines and Vaccination Congress, March 18-19, 2019, New York, USA
Related Societies:
International Society of Vaccines (ISV), Infectious Diseases Society of America, Edward Jenner Society, Canadian Paediatric Society, British Society for Immunology, Arizona Humane Society, San Diego Humane Society.
Session 02: Vaccine Design and Development
Vaccine design and development have been used against infectious diseases, so it is basically required a revolution in the approach to vaccine design and development. Particular vaccines are involved to act against specific diseases. For example polio vaccines are recommended for vaccination against polio virus. New technologies such as genomics, proteomics, functional genomics, and synthetic chemistry can be used for the rational identification of antigens, the synthesis of complex glycans, the generation of engineered carrier proteins, and much more that are needed in designing vaccines.Vaccine design and development services help to reduce the cost of failure and increase the chance of clinical success
Related Conferences:
International Conference on Immunology & Vaccination, September 17-19, 2018, Paris, France; Annual Vaccines Research & Development Conference, July 13-14, 2018, Baltimore, MD; European Congress on Immunology, September 2-5, 2018, Amsterdam, Netherlands; ISV 2018 Congress, October 28-30, 2018, Atlanta, USA; Vaccine Congress, September 16-19, 2018, Budapest, Hungary; Annual Congress and Expo on Vaccines & Immunology, August 27-29, 2018, Amsterdam, Netherlands; World Congress on Vaccines & Immunization, October 22-23, 2018, Osaka, Japan
Related Societies:
Chesapeake Humane Society, Inland Valley Humane Society and S.P.C.A., CT Humane Society, Licking County Humane Society, Bay Area Humane Society, Global Science Child Health and Society, Michigan Humane Society.
Session 03: Vaccine Development and Implementation
Vaccine development is an activity that focuses on a variety of technological initiatives and applied research, which enhance and promote improved systems and practices for vaccine safety. In the past year, the unprecedented Ebola disease outbreak galvanized research and industry response and as we continue to search for solutions, we must review the lessons learned in order to overcome the current challenges. Vaccine manufacturing and development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement. The current system for developing, testing, and regulating vaccines developed during the 20th century as the groups involved standardized their procedures and regulations.
Related Conferences:
Global Conference on Vaccines Research & Development, March 25-26, 2019, Milan, Italy; Canadian Immunization Conference, December 5-8, 2018, Ontario, Canada; North Dakota Conference on Immunization, July 17-18, 2018 Bismarck, ND; Virology & Vaccines, August 16-18, 2018, London, UK; The Vaccines & Immunology Conclave, September 18-20,2018, Dubai, UAE; International Conference on Immunization research & development, November 9-10, 2018, Atlanta, USA; International Congress on Vaccines & Immunology during September 19-20, 2018 in Amsterdam, Netherlands.
Related Societies:
Vanderburgh Humane Society, Humane Society of Huron Valley, American Cancer Society, Kitsap Humane Society, Peninsula Humane Society & SPCA, The Toronto Humane Society, Humane Society of Indianapolis.
Session 04: Public Health Effectiveness of Vaccine Implementation
Vaccines have helped to save millions of lives. Infectious disease has always impacted humanity but with the development of vaccines the occurrence of infectious disease has been decreases. Vaccines made life more comfortable and hence various researches are still going on to cure various vaccine preventable diseases. Polio infection is on its way to eradication from all the countries and we will discuss more on the steps to eradicate polio. Polio eradication is a greatest achievement in field vaccine development. Public Health's Immunization Program aims to assist all in attaining optimal health through knowledge of and access to immunizations.
Related Conferences:
Conference on Strategic Partnering for the Global Vaccine Industry, October 29-31, 2018, Lisbon, Portugal; Global Summit on Vaccines and Vaccination, August 23-25, 2018, Las Vegas, USA; World Vaccine Congress Washington congress, April 14- 17, 2019, Washington DC, USA; International Conference on Vaccines Research & Development, November 13-15, 2018, Baltimore, MD; 3rd International Conference on Immunology and Vaccines, November 7-9, 2018, Tokyo, Japan; Annual Congress on Vaccines and Clinical Trials, July 27-28, 2018, Vancouver, Canada; 33rd Annual Vaccines and Vaccination Congress, March 18-19, 2019, New York, USA
Related Societies:
International Society of Vaccines (ISV), Infectious Diseases Society of America, Edward Jenner Society, Canadian Paediatric Society, British Society for Immunology, Arizona Humane Society, San Diego Humane Society.
Session 05: Managing and Storage of Vaccines
Immunizations help save lives, prevent serious illnesses, and are recognized as one of the most effective public health interventions available today. Vaccines immunology programs are among the most cost-effective ways to prevent disease. The success of these programs depends heavily upon the high immunization coverage of the target group and vaccine inventory management, including proper storage and handling of vaccines. This document is intended to assist all health care providers with how to properly store and handle provincially funded vaccines. Prior to storing vaccine, health care providers are required to understand and meet with the vaccine storage and handling requirements indicated in this document.
Related Conferences:
International Conference on Immunology & Vaccination, September 17-19, 2018, Paris, France; Annual Vaccines Research & Development Conference, July 13-14, 2018, Baltimore, MD; European Congress on Immunology, September 2-5, 2018, Amsterdam, Netherlands; ISV 2018 Congress, October 28-30, 2018, Atlanta, USA; Vaccine Congress, September 16-19, 2018, Budapest, Hungary; Annual Congress and Expo on Vaccines & Immunology, August 27-29, 2018, Amsterdam, Netherlands; World Congress on Vaccines & Immunization, October 22-23, 2018, Osaka, Japan
Chesapeake Humane Society, Inland Valley Humane Society and S.P.C.A., CT Humane Society, Licking County Humane Society, Bay Area Humane Society, Global Science Child Health and Society, Michigan Humane Society.
Session 06: Vaccine Adjuvants
Vaccine adjuvants is a part of a vaccine that helps to create a stronger immune response in the patient’s body. Some vaccines prepared from weakened or dead germs contain naturally occurring adjuvants and aid the body produce a strong protective immune response. With the advancement of new and less reactogenic vaccine antigens, additionally comes the requirement for more viable adjuvants that will encourage the acceptance of adaptive immune responses. Vaccines made with adjuvants ensure the body to produce an immune response to protect the patient from the germ he or she is being vaccinated against. Vaccine adjuvants improve the body's immune response and often allow for smaller amounts of an inactivated virus or bacteria to be used in a vaccine. Aluminium salts, such as aluminium hydroxide, aluminium phosphate, and aluminium potassium sulphate have been used safely as adjuvant in vaccines.
Related Conferences:
Global Conference on Vaccines Research & Development, March 25-26, 2019, Milan, Italy; Canadian Immunization Conference, December 5-8, 2018, Ontario, Canada; North Dakota Conference on Immunization, July 17-18, 2018 Bismarck, ND; Virology & Vaccines, August 16-18, 2018, London, UK; The Vaccines & Immunology Conclave, September 18-20,2018, Dubai, UAE; International Conference on Immunization research & development, November 9-10, 2018, Atlanta, USA; International Congress on Vaccines & Immunology during September 19-20, 2018 in Amsterdam, Netherlands.
Related Societies:
Vanderburgh Humane Society, Humane Society of Huron Valley, American Cancer Society, Kitsap Humane Society, Peninsula Humane Society & SPCA, The Toronto Humane Society, Humane Society of Indianapolis.
Vaccines and vaccination is generally considered to be the most effective method of preventing infectious diseases. All vaccinations work by presenting a foreign antigen to the immune system in order to evoke an immune response. The purpose of every vaccination is to present a particular antigen or set of antigens to the immune system in order to evoke a relevant immune response. Vaccines help make you immune to serious diseases without getting sick first. Without a vaccine, you must actually get a disease in order to become immune to the germ that causes it. Vaccines work best when they are given at certain ages. Proper timing of vaccination is key point to be noted and we would discuss various vaccines available for infants, adolescents and adults along with their schedules and risks factors involved.
Related Conferences:
Conference on Strategic Partnering for the Global Vaccine Industry, October 29-31, 2018, Lisbon, Portugal; Global Summit on Vaccines and Vaccination, August 23-25, 2018, Las Vegas, USA; World Vaccine Congress Washington congress, April 14- 17, 2019, Washington DC, USA; International Conference on Vaccines Research & Development, November 13-15, 2018, Baltimore, MD; 3rd International Conference on Immunology and Vaccines, November 7-9, 2018, Tokyo, Japan; Annual Congress on Vaccines and Clinical Trials, July 27-28, 2018, Vancouver, Canada; 33rd Annual Vaccines and Vaccination Congress, March 18-19, 2019, New York, USA
Related Societies:
International Society of Vaccines (ISV), Infectious Diseases Society of America, Edward Jenner Society, Canadian Paediatric Society, British Society for Immunology, Arizona Humane Society, San Diego Humane Society.
Session 08: Conjugate Vaccines
Conjugate Vaccines target several leading causes of vaccine-preventable deaths. Conjugate vaccines also have antigens or toxoids, often from the same bacteria, linked to the sugar molecules. Conjugate vaccines only use a small part of a bacterium linked to carrier protein. Conjugate vaccines are primarily used for the prevention of bacterial infections. Polysaccharide protein conjugate vaccines comprise of polysaccharides, generally from the surface coat of bacteria, linked to protein carriers. The advantages of the conjugate vaccines are their capacity to create immunological memory and to decrease asymptomatic carriage of the microbes, resulting in marked herd immunity. Conjugate vaccines can reduce complexity and increase coverage.
Related Conferences:
International Conference on Immunology & Vaccination, September 17-19, 2018, Paris, France; Annual Vaccines Research & Development Conference, July 13-14, 2018, Baltimore, MD; European Congress on Immunology, September 2-5, 2018, Amsterdam, Netherlands; ISV 2018 Congress, October 28-30, 2018, Atlanta, USA; Vaccine Congress, September 16-19, 2018, Budapest, Hungary; Annual Congress and Expo on Vaccines & Immunology, August 27-29, 2018, Amsterdam, Netherlands; World Congress on Vaccines & Immunization, October 22-23, 2018, Osaka, Japan
Chesapeake Humane Society, Inland Valley Humane Society and S.P.C.A., CT Humane Society, Licking County Humane Society, Bay Area Humane Society, Global Science Child Health and Society, Michigan Humane Society.
Session 09: Bacterial Vaccines
A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes. Bacterial vaccines is a preparation of killed or attenuated bacteria used as an active immunizing agent to prevent diseases like plague, influenza and a large number of deaths could be reduced by increased use of present vaccines and even more deaths can be prevented by the future use of new vaccines being developed. We would be glad to welcome and bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. Vaccine Design 2018 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.
Related Conferences:
Global Conference on Vaccines Research & Development, March 25-26, 2019, Milan, Italy; Canadian Immunization Conference, December 5-8, 2018, Ontario, Canada; North Dakota Conference on Immunization, July 17-18, 2018 Bismarck, ND; Virology & Vaccines, August 16-18, 2018, London, UK; The Vaccines & Immunology Conclave, September 18-20,2018, Dubai, UAE; International Conference on Immunization research & development, November 9-10, 2018, Atlanta, USA; International Congress on Vaccines & Immunology during September 19-20, 2018 in Amsterdam, Netherlands.
Related Societies:
Vanderburgh Humane Society, Humane Society of Huron Valley, American Cancer Society, Kitsap Humane Society, Peninsula Humane Society & SPCA, The Toronto Humane Society, Humane Society of Indianapolis.
Session 10: Plant Derived Vaccines
Plant-determined immunizations show another option to traditonal vaccine by encouraging sheltered and viable oral delivery through utilization of eatable plant tissue. Numerous infectious diseases enter the body through mucosal surfaces, for example, the gut, and accordingly, vaccines expressed in the form of edible plant tissues offer a select preferred advantage. The plant tissues can secure the antigen as it goes through the digestive tract. Vaccines derived from transgenic plants are convenient and inexpensive source for various bacterial, viral, protozoan and autoimmune diseases with lower capital costs.
Related Conferences:
Conference on Strategic Partnering for the Global Vaccine Industry, October 29-31, 2018, Lisbon, Portugal; Global Summit on Vaccines and Vaccination, August 23-25, 2018, Las Vegas, USA; World Vaccine Congress Washington congress, April 14- 17, 2019, Washington DC, USA; International Conference on Vaccines Research & Development, November 13-15, 2018, Baltimore, MD; 3rd International Conference on Immunology and Vaccines, November 7-9, 2018, Tokyo, Japan; Annual Congress on Vaccines and Clinical Trials, July 27-28, 2018, Vancouver, Canada; 33rd Annual Vaccines and Vaccination Congress, March 18-19, 2019, New York, USA
Related Societies:
International Society of Vaccines (ISV), Infectious Diseases Society of America, Edward Jenner Society, Canadian Paediatric Society, British Society for Immunology, Arizona Humane Society, San Diego Humane Society.
Session 11: Futuristic Approaches
DNA vaccines are used efficiently to stimulate humoral response and cellular response in animal and humans. Foreign gene will be incorporated in live host cell through R-DNA technology which induces the gene expression in the host cell. DNA vaccines are composed of bacterial plasmids. Expression plasmids are use in DNA based vaccines. Recombinant vaccines consist of some pathogen sub-units.Recombinant Vaccines are synthetic peptides that represent the protein component that induces an immune response.One of the best examples of recombinant protein vaccine currently in use in humans is the vaccine against Hepatitis B Virus (HBV).
Related Conferences:
International Conference on Immunology & Vaccination, September 17-19, 2018, Paris, France; Annual Vaccines Research & Development Conference, July 13-14, 2018, Baltimore, MD; European Congress on Immunology, September 2-5, 2018, Amsterdam, Netherlands; ISV 2018 Congress, October 28-30, 2018, Atlanta, USA; Vaccine Congress, September 16-19, 2018, Budapest, Hungary; Annual Congress and Expo on Vaccines & Immunology, August 27-29, 2018, Amsterdam, Netherlands; World Congress on Vaccines & Immunization, October 22-23, 2018, Osaka, Japan
Chesapeake Humane Society, Inland Valley Humane Society and S.P.C.A., CT Humane Society, Licking County Humane Society, Bay Area Humane Society, Global Science Child Health and Society, Michigan Humane Society.
Session 12: Vaccines for Infants, Children and Adults
A vaccine is a biological preparation that provides active acquired immunity to a particular disease and dates it uses back from a long time. Infections are always better if prevented then trying to cure them at later stages and the best way to ensure we are protected is to ask our healthcare provider if our vaccinations are up to date. Within one year of birth vaccines against diseases like diptheria, MMR are administered. Proper timing of vaccination is another key point to be noted and we would discuss various vaccines available for infants, adolescents and adults along with their schedules and risks factors involved.
Related Conferences:
Global Conference on Vaccines Research & Development, March 25-26, 2019, Milan, Italy; Canadian Immunization Conference, December 5-8, 2018, Ontario, Canada; North Dakota Conference on Immunization, July 17-18, 2018 Bismarck, ND; Virology & Vaccines, August 16-18, 2018, London, UK; The Vaccines & Immunology Conclave, September 18-20,2018, Dubai, UAE; International Conference on Immunization research & development, November 9-10, 2018, Atlanta, USA; International Congress on Vaccines & Immunology during September 19-20, 2018 in Amsterdam, Netherlands.
Related Societies:
Vanderburgh Humane Society, Humane Society of Huron Valley, American Cancer Society, Kitsap Humane Society, Peninsula Humane Society & SPCA, The Toronto Humane Society, Humane Society of Indianapolis.
Session 13: Human Vaccines
Vaccines protect and prevent us from various diseases. Usually human are affected by diseases like Hepatitis B, HPV, Tuberculosis and these virus related cancers. There was experience of recital of diseases like chickenpox, mumps etc,. prior to the development and discovery of these vaccines. Vaccines present good value among health interventions and prevent from various diseases that cause discomfort and disability. Many research in science and its advances may help in production of novel vaccines. Recent development in vaccine production like recombinant, conjugate vaccines have been very successful in preventing diseases.
Related Conferences:
Conference on Strategic Partnering for the Global Vaccine Industry, October 29-31, 2018, Lisbon, Portugal; Global Summit on Vaccines and Vaccination, August 23-25, 2018, Las Vegas, USA; World Vaccine Congress Washington congress, April 14- 17, 2019, Washington DC, USA; International Conference on Vaccines Research & Development, November 13-15, 2018, Baltimore, MD; 3rd International Conference on Immunology and Vaccines, November 7-9, 2018, Tokyo, Japan; Annual Congress on Vaccines and Clinical Trials, July 27-28, 2018, Vancouver, Canada; 33rd Annual Vaccines and Vaccination Congress, March 18-19, 2019, New York, USA
Related Societies:
International Society of Vaccines (ISV), Infectious Diseases Society of America, Edward Jenner Society, Canadian Paediatric Society, British Society for Immunology, Arizona Humane Society, San Diego Humane Society.
Session 14: HIV vaccines
These Vaccines protect individuals who do not have HIV from contracting that virus,or therapeutic effect for persons who have or later contract HIV. There is no effective HIV vaccines currently, but research projects on clinical trials are trying to build one. There is evidence that a vaccine may be possible. Preventative medications such as antiretroviral treatments have been put into use to help prevent infection, but do not work as well as a vaccine would. The need for advance purchase commitment is a challenge in production of vaccines because governments bring the price down to marginal cost after the vaccine is being developed. Recognition of viral proteins causing various diseases by priming acquired immunity through vaccines has failed in the case of HIV. Some have stated that an HIV vaccine may not be possible without significant theoretical advances.
Related Conferences:
International Conference on Immunology & Vaccination, September 17-19, 2018, Paris, France; Annual Vaccines Research & Development Conference, July 13-14, 2018, Baltimore, MD; European Congress on Immunology, September 2-5, 2018, Amsterdam, Netherlands; ISV 2018 Congress, October 28-30, 2018, Atlanta, USA; Vaccine Congress, September 16-19, 2018, Budapest, Hungary; Annual Congress and Expo on Vaccines & Immunology, August 27-29, 2018, Amsterdam, Netherlands; World Congress on Vaccines & Immunization, October 22-23, 2018, Osaka, Japan
Chesapeake Humane Society, Inland Valley Humane Society and S.P.C.A., CT Humane Society, Licking County Humane Society, Bay Area Humane Society, Global Science Child Health and Society, Michigan Humane Society.
Session 15: Mucosal Vaccines
Mucosal tissues (e.g. nasal, oral, ocular, rectal, vaginal) cover a large surface of the body. It is critical to develop strategies for neutralizing the infectious agent at these surfaces because infections are initiated at these sites. Mucosal vaccination involves the administration of vaccines at one or more mucosal sites leading to induction of immune responses at that site, or other mucosal sites. Immunization involves the delivery of antigens to the mucosal immune system. The antigen delivery systems may comprise a simple buffer solution with/without adjuvants or an advanced particulate formulation, such as liposomes or nanoparticles. The most commonly evaluated route for mucosal antigen delivery is oral, but other routes have also been explored.
Related Conferences:
Global Conference on Vaccines Research & Development, March 25-26, 2019, Milan, Italy; Canadian Immunization Conference, December 5-8, 2018, Ontario, Canada; North Dakota Conference on Immunization, July 17-18, 2018 Bismarck, ND; Virology & Vaccines, August 16-18, 2018, London, UK; The Vaccines & Immunology Conclave, September 18-20,2018, Dubai, UAE; International Conference on Immunization research & development, November 9-10, 2018, Atlanta, USA; International Congress on Vaccines & Immunology during September 19-20, 2018 in Amsterdam, Netherlands.
Related Societies:
Vanderburgh Humane Society, Humane Society of Huron Valley, American Cancer Society, Kitsap Humane Society, Peninsula Humane Society & SPCA, The Toronto Humane Society, Humane Society of Indianapolis.
It's important to have the right vaccinations and health advice before you travel. Its good to get the right advice - based on ones medical history, duration and season of travel. Some countries require proof of vaccination for certain diseases, like yellow fever or polio. And traveling in developing countries and rural areas may bring you into contact with more diseases, which means you might need more vaccines before you visit. It’s important to get vaccinated at least 4 to 6 weeks before you travel. This will give the vaccines time to start working, so you’re protected while you’re traveling. It will also usually make sure there’s enough time for you to get vaccines that require more than 1 dose.
Related Conferences:
Conference on Strategic Partnering for the Global Vaccine Industry, October 29-31, 2018, Lisbon, Portugal; Global Summit on Vaccines and Vaccination, August 23-25, 2018, Las Vegas, USA; World Vaccine Congress Washington congress, April 14- 17, 2019, Washington DC, USA; International Conference on Vaccines Research & Development, November 13-15, 2018, Baltimore, MD; 3rd International Conference on Immunology and Vaccines, November 7-9, 2018, Tokyo, Japan; Annual Congress on Vaccines and Clinical Trials, July 27-28, 2018, Vancouver, Canada; 33rd Annual Vaccines and Vaccination Congress, March 18-19, 2019, New York, USA
Related Societies:
International Society of Vaccines (ISV), Infectious Diseases Society of America, Edward Jenner Society, Canadian Paediatric Society, British Society for Immunology, Arizona Humane Society, San Diego Humane Society.
Session 17: Fish Vaccines
Vaccination plays an important role in large-scale commercial fish farming. In general, empirically developed vaccines based on inactivated bacterial pathogens have proven to be very efficacious in fish. Fewer commercially available viral vaccines and no parasite vaccines exist. Substantial efficacy data are available for new fish vaccines and advanced technology has been implemented.Fish vaccines can be delivered the same way we immunize warm-blooded animals. Fish can be immunized by immersion in vaccine for a short period of time. They can be immunized by injection, intramuscularly or intraperitoneally, and orally by mixing vaccines with feed. Vaccines have been a major factor in decreasing the use of antibiotics in aquaculture while keeping fish healthy. However, a vaccine is only effective if it is delivered properly into the fish, in the correct place and at the correct dose.
Related Conferences:
International Conference on Immunology & Vaccination, September 17-19, 2018, Paris, France; Annual Vaccines Research & Development Conference, July 13-14, 2018, Baltimore, MD; European Congress on Immunology, September 2-5, 2018, Amsterdam, Netherlands; ISV 2018 Congress, October 28-30, 2018, Atlanta, USA; Vaccine Congress, September 16-19, 2018, Budapest, Hungary; Annual Congress and Expo on Vaccines & Immunology, August 27-29, 2018, Amsterdam, Netherlands; World Congress on Vaccines & Immunization, October 22-23, 2018, Osaka, Japan
Chesapeake Humane Society, Inland Valley Humane Society and S.P.C.A., CT Humane Society, Licking County Humane Society, Bay Area Humane Society, Global Science Child Health and Society, Michigan Humane Society.
Related Conferences:
Global Conference on Vaccines Research & Development, March 25-26, 2019, Milan, Italy; Canadian Immunization Conference, December 5-8, 2018, Ontario, Canada; North Dakota Conference on Immunization, July 17-18, 2018 Bismarck, ND; Virology & Vaccines, August 16-18, 2018, London, UK; The Vaccines & Immunology Conclave, September 18-20,2018, Dubai, UAE; International Conference on Immunization research & development, November 9-10, 2018, Atlanta, USA; International Congress on Vaccines & Immunology during September 19-20, 2018 in Amsterdam, Netherlands.
Related Societies:
Vanderburgh Humane Society, Humane Society of Huron Valley, American Cancer Society, Kitsap Humane Society, Peninsula Humane Society & SPCA, The Toronto Humane Society, Humane Society of Indianapolis.
Session 19: Insilico Based Vaccine Designing
Insilico base designing offers inexpensive, specific, potential and easy means of vaccine development and a standard approach in this post-genomic era. Epitope based vaccine designing has become a promising approach with advances in genomics, proteomics. Prediction of epitopes via in silico tools in vaccine designing process can significantly minimize the time and cost required in the development process. Traditional methods of vaccine production can be augmented by insilico approaches.
Related Conferences:
Conference on Strategic Partnering for the Global Vaccine Industry, October 29-31, 2018, Lisbon, Portugal; Global Summit on Vaccines and Vaccination, August 23-25, 2018, Las Vegas, USA; World Vaccine Congress Washington congress, April 14- 17, 2019, Washington DC, USA; International Conference on Vaccines Research & Development, November 13-15, 2018, Baltimore, MD; 3rd International Conference on Immunology and Vaccines, November 7-9, 2018, Tokyo, Japan; Annual Congress on Vaccines and Clinical Trials, July 27-28, 2018, Vancouver, Canada; 33rd Annual Vaccines and Vaccination Congress, March 18-19, 2019, New York, USA
Related Societies:
International Society of Vaccines (ISV), Infectious Diseases Society of America, Edward Jenner Society, Canadian Paediatric Society, British Society for Immunology, Arizona Humane Society, San Diego Humane Society.
Session 20: Vaccine Efficacy and Safety
Vaccines have significantly reduced the burden of infectious diseases. Recognized vaccine safety issues are commonly reported while reviews of Vaccine adjuvants are few. Vaccines are developed in accordance with the highest standards of safety because vaccines must be safe for use by as many people as possible. Individuals respond differently to vaccines, and there is no way to absolutely guess the reaction of a specific individual to a particular vaccine. Immunization is the safest and most effective public health tool available for preventing disease and death. Efficacious vaccines protect individuals if administered before exposure.
Related Conferences:
International Conference on Immunology & Vaccination, September 17-19, 2018, Paris, France; Annual Vaccines Research & Development Conference, July 13-14, 2018, Baltimore, MD; European Congress on Immunology, September 2-5, 2018, Amsterdam, Netherlands; ISV 2018 Congress, October 28-30, 2018, Atlanta, USA; Vaccine Congress, September 16-19, 2018, Budapest, Hungary; Annual Congress and Expo on Vaccines & Immunology, August 27-29, 2018, Amsterdam, Netherlands; World Congress on Vaccines & Immunization, October 22-23, 2018, Osaka, Japan
Chesapeake Humane Society, Inland Valley Humane Society and S.P.C.A., CT Humane Society, Licking County Humane Society, Bay Area Humane Society, Global Science Child Health and Society, Michigan Humane Society.
Session 21: Immunization Safety and Vaccination Schedule
Researchers have proved that vaccine are safe to be taken. But still many find ways to skip or delay the uptake of vaccines. Survey says that regular vaccination can prevent us from various diseases. It will lead to risk of life in spreading out dosage of vaccines. There are many misconception about immunization.Not only would diseases not be disappearing without vaccines, but if we were to stop vaccinating, they would come back. Misconception often receives considerable publicity. Regular vaccination with prescribed dosage is always appreciable.
Related Conferences:
Global Conference on Vaccines Research & Development, March 25-26, 2019, Milan, Italy; Canadian Immunization Conference, December 5-8, 2018, Ontario, Canada; North Dakota Conference on Immunization, July 17-18, 2018 Bismarck, ND; Virology & Vaccines, August 16-18, 2018, London, UK; The Vaccines & Immunology Conclave, September 18-20,2018, Dubai, UAE; International Conference on Immunization research & development, November 9-10, 2018, Atlanta, USA; International Congress on Vaccines & Immunology during September 19-20, 2018 in Amsterdam, Netherlands.
Related Societies:
Vanderburgh Humane Society, Humane Society of Huron Valley, American Cancer Society, Kitsap Humane Society, Peninsula Humane Society & SPCA, The Toronto Humane Society, Humane Society of Indianapolis.
Vaccine Research and Development involves vaccine research in the field of infectious diseases in the collective integration, including cancer, AIDS and allergies.New vaccines are constantly being researched and developed. There has been a steady progression in the advancement of vaccines that has led to development of licensed vaccines.Combination vaccines have been introduced which can prevent several diseases at once. Risk profile of vaccine against chronic diseases is moderately high when compared to those against acute diseases.
Related Conferences:
Conference on Strategic Partnering for the Global Vaccine Industry, October 29-31, 2018, Lisbon, Portugal; Global Summit on Vaccines and Vaccination, August 23-25, 2018, Las Vegas, USA; World Vaccine Congress Washington congress, April 14- 17, 2019, Washington DC, USA; International Conference on Vaccines Research & Development, November 13-15, 2018, Baltimore, MD; 3rd International Conference on Immunology and Vaccines, November 7-9, 2018, Tokyo, Japan; Annual Congress on Vaccines and Clinical Trials, July 27-28, 2018, Vancouver, Canada; 33rd Annual Vaccines and Vaccination Congress, March 18-19, 2019, New York, USA
Related Societies:
International Society of Vaccines (ISV), Infectious Diseases Society of America, Edward Jenner Society, Canadian Paediatric Society, British Society for Immunology, Arizona Humane Society, San Diego Humane Society.
Vaccine Design 2018
Theme: “Eploring, Envisioning Innovations on Vaccine Designing”.
Summary
Traditionally Vaccines have been used to eradicate infectious diseases, which started with Small Pox. Apparently In the last few years there is great advancement towards vaccine design and its development. In the Era of Molecular biology the innovative technologies such as genomics, proteomics, and functional genomics are used for the rational identification of antigens, generation of engineered carrier proteins and much more. The research in this area has always been more exciting with ever new outbreak the nature throws from influenza to Zika.
Vaccine Design 2018 is an ideal forum for the researchers and Healthcare professionals to discuss on the current advancements in Vaccine design towards the most precise way of immunization.
Importance and Scope
“24th International Conference on Vaccine Design, Production & Safety” to be held on September 17-18, 2018, Lisbon, Portugal hosted by Pulsus Group, the conference will explore the advances in Vaccine Research, Development & Design. This conference could be an exceptional event that brings along a novel and International mixture of giant and medium cognizance on Vaccines and its safety, leading universities engendering the conference an ideal platform to apportion expertise, foster collaborations across trade and world, and assess elevating technologies across the world.
Conference Highlights:
1. Production and Research of Vaccines
2. Vaccine Design and Development
3. Vaccine Development and Implementation
4. Public Health Effectiveness of Vaccine Implementation
5. Managing and Storage of Vaccines
6. Vaccine Adjuvants
7. Vaccine and Vaccination
8. Conjugate Vaccines
9. Bacterial Vaccines
10. Plant Derived Vaccines
11. Futuristic Approaches
12. Vaccines for Infants, Children and Adults
13. Human Vaccines
14. HIV vaccines
15. Mucosal vaccines
16. Travel Immunization
17. Fish Vaccines
18. Veterinary Vaccines
19. Insilico Based Vaccine Designing
20 Vaccine Efficacy and Safety
21. Immunization Safety and Vaccination Schedule
22. Vaccine Research and Development
Major Vaccine Manufacturers
Industries Associated with Vaccines
|
Lisbon |
Portugal |
Worldwide |
|
|
|
Universities Associated with Vaccine Research
|
Lisbon |
Portugal |
Worldwide |
|
|
|
Vaccine Production:
Global Funding Bodies:
Target Audience:
The conference discusses the latest research outcomes and technological advancements in regards with Vaccine development matching with latest trend; it as well brings together leading Health care professionals Immunologists, Physicians, Research Scholars, Students along with Industries. This forum is for professionals to exchange and share their views on critical aspects of Vaccines research. Vaccine Design 2018 will give you the opportunity to meet the main experts around the world, present your own discovery or work, and interact with your peers. Furthermore, the stimulating scientific program will provide you to enrich professionally and socially, providing the chance to keep in touch with other participants for establishing any new future collaborations.’
Pulsus Group invites participants from all over the world to attend “24th International Conference on Vaccine Design, Production & Safety” to be held on September 17-18, 2018, Lisbon, Portugal. Vaccine Design 2018 is based on the theme “Exploring, Envisioning Innovations on Vaccine Designing”. This includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.